BioCentury
ARTICLE | Company News

Altus Formulation, Halo Pharmaceutical Inc. deal

May 20, 2013 7:00 AM UTC

Drug development and commercial manufacturing services company Halo acquired an undisclosed minority stake in drug formulation company Altus. The companies also partnered to allow Halo to provide its clients with Altus' technology and services, which include solutions for drug solubility, bioavailability, tamper and abuse deterrence and drug dosage delivery issues. The companies declined to disclose details. ...